Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal logo Université Clermont Auvergne & associés

Human Nutrition Unit

Zone de texte éditable et éditée et rééditée

Dr Julien Averous

Julien Averous' profile

Field of research

            Amino acids exhibit two important characteristics. Firstly, in mammals, 9 amino acids, called indispensable amino acid, cannot be synthesized de novo. Secondly, there is no specific storage of amino acids analogous to glycogen for glucose or triglyceride of adipose tissue for lipids. Consequently, when necessary, an organism has to hydrolyse endogenous protein to produce free amino acids. This loss of protein will be at the expense of essential elements. At the cellular, amino acid availability regulates a number of signal transduction pathways that leads to activation of specific functions (transcription, autophagy, …) playing a key role in adaptation to nutrient stress. The GCN2 and the mTORC1 signaling pathways are well known to be regulated by amino acid availability, and to share common functions, in particular the control of protein synthesis. Despite recent significant progress in the understanding of the regulation of mTORC1 by amino acids, key aspects of this process remain unsolved. This topic is the centre of a particular attention, given the fundamental importance of mTORC1 in many physiological functions and in several pathologies. Contrary to mTORC1, the regulation of GCN2 activity by amino acid availability has been well characterized. It relies on the capacity of GCN2 to sense the increased level of uncharged tRNAs upon amino acid scarcity. It is only recently that, an increasing number of data from animal models or clinical studies reveal an important role of the GCN2 pathway in the regulation of physiological and pathological processes. Beyond the role of these two pathways, it has to be considered that other molecular mechanisms must be involved in the adaptation of cell to the modifications of amino acid availability. The comprehension of these different mechanisms is essential to better apprehend the impact of amino acids in physiological and pathological situations.

Research activities

Amino acid sensing and mTORC1/GCN2 interaction

We focused our investigation on the interaction between the GCN2/eIF2a pathway and the mTORC1 pathway. This pathway is well-known to be regulated by amino acid availability and is a master regulator of cell growth. Different studies suggest a role of GCN2 in the regulation of mTORC1. This project led us to complement the accepted model of mTORC1 regulation by amino acids and in particular by leucine. We demonstrated that leucine activates mTORC1 without causing any detectable modification of the lysosomal localization of mTOR. Moreover, leucine can promote mTORC1 signaling independently of the lysosomal localization of mTOR.

Identification of the molecular mechanisms involved in the adaptation of cancer cells to amino acid starvation

Tumor development is closely associated with deep changes in cellular metabolism. The uncontrolled division of cancer cells involves a major expansion of the tumor, which will result in an inadequate availability of nutrients, especially oxygen, glucose and amino acids. If this nutrient-deprived environment contributes to the formation of the necrotic area, it also exerts a pressure of selection on tumor cells. Due to their genetic instability, secondary mutations are likely to generate cells highly resistant to nutrient deficiencies able to survive and colonize the tumor ("Darwinian” selection). In this project we focus on the identification of the molecular mechanisms involved in the long-term adaptation to an amino acids deficiency. We chose an original approach that consists in generating cellular tools by functional genetics. It consists in exerting a very strong selection pressure on mouse embryonic fibroblasts by culturing them for several months in a medium containing very low level of amino acids. Even though most of the cells died, some of them survived and formed clones that we isolated and kept on a strong selective pressure.


Mesclon F, Lambert-Langlais S, Carraro V, Parry L, Hainault I, Jousse C, Maurin AC, Bruhat A, Fafournoux P, Averous J. Decreased ATF4 expression as a mechanism of acquired resistance to long-term amino acid limitation in cancer cells. Oncotarget. 2017 Apr 18;8(16):27440-27453.

Chaveroux C, Bruhat A, Carraro V, Jousse C, Averous J, Maurin AC, Parry L, Mesclon F, Muranishi Y, Cordelier P, Meulle A, Baril P, Do Thi A, Ravassard P, Mallet J, Fafournoux P. Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids. Nat Biotechnol. 2016 Jul;34(7):746-51.

Chaveroux C, Carraro V, Canaple L, Averous J, Maurin AC, Jousse C, Muranishi Y, Parry L, Mesclon F, Gatti E, Mallet J, Ravassard P, Pierre P, Fafournoux P, Bruhat A. In vivo imaging of the spatiotemporal activity of the eIF2α-ATF4 signaling pathway: Insights into stress and related disorders. Sci Signal. 2015 Apr 28;8(374)

Averous J, Lambert-Langlais S, Carraro V, Gourbeyre O, Parry L, B'Chir W, Muranishi Y, Jousse C, Bruhat A, Maurin AC, Proud CG, Fafournoux P. Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids. Cell Signal. 2014 Sep;26(9):1918-27.

B'chir W, Maurin AC, Carraro V, Averous J, Jousse C, Muranishi Y, Parry L, Stepien G, Fafournoux P, Bruhat A. The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013 Sep;41(16):7683-99.

Averous J, Gabillard JC, Seiliez I, Dardevet D. Leucine limitation regulates myf5 and myoD expression and inhibits myoblast differentiation. Exp Cell Res. 2012 Feb 1;318(3):217-27.

Averous J, Lambert-Langlais S, Cherasse Y, Carraro V, Parry L, B'chir W, Jousse C, Maurin AC, Bruhat A, Fafournoux P. Amino acid deprivation regulates the stress-inducible gene p8 via the GCN2/ATF4 pathway. Biochem Biophys Res Commun. 2011 Sep 16;413(1):24-9.